BioLife Solutions, Inc. (BLFS)
USD 24.98
(-7.03%)
USD 24.98
(-7.03%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 412.71 Million USD | -8.33% |
| 2022 | 450.22 Million USD | -18.53% |
| 2021 | 552.6 Million USD | 135.32% |
| 2020 | 234.82 Million USD | 152.47% |
| 2019 | 93.01 Million USD | 104.57% |
| 2018 | 45.46 Million USD | 274.43% |
| 2017 | 12.14 Million USD | 53.19% |
| 2016 | 7.92 Million USD | -35.92% |
| 2015 | 12.36 Million USD | -23.04% |
| 2014 | 16.07 Million USD | 379.31% |
| 2013 | 3.35 Million USD | 5.79% |
| 2012 | 3.16 Million USD | 90.72% |
| 2011 | 1.66 Million USD | 26.96% |
| 2010 | 1.3 Million USD | -1.87% |
| 2009 | 1.33 Million USD | 13.95% |
| 2008 | 1.17 Million USD | 61.24% |
| 2007 | 726.01 Thousand USD | 29.55% |
| 2006 | 560.43 Thousand USD | 25.35% |
| 2005 | 447.1 Thousand USD | -46.34% |
| 2004 | 833.26 Thousand USD | -71.89% |
| 2003 | 2.96 Million USD | 844.38% |
| 2002 | 313.84 Thousand USD | -82.33% |
| 2001 | 1.77 Million USD | -55.46% |
| 2000 | 3.98 Million USD | 84.74% |
| 1999 | 2.15 Million USD | -20.84% |
| 1998 | 2.72 Million USD | -29.69% |
| 1997 | 3.87 Million USD | -35.83% |
| 1996 | 6.04 Million USD | -28.06% |
| 1995 | 8.4 Million USD | -7.66% |
| 1994 | 9.1 Million USD | 8.33% |
| 1993 | 8.4 Million USD | -35.38% |
| 1992 | 13 Million USD | 132.14% |
| 1991 | 5.6 Million USD | 60.0% |
| 1990 | 3.5 Million USD | 600.0% |
| 1989 | 500 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 374.97 Million USD | -6.63% |
| 2024 Q1 | 401.6 Million USD | -2.69% |
| 2023 Q1 | 446.47 Million USD | -0.83% |
| 2023 Q2 | 433.17 Million USD | -2.98% |
| 2023 FY | 412.71 Million USD | -8.33% |
| 2023 Q4 | 412.71 Million USD | 0.38% |
| 2023 Q3 | 411.15 Million USD | -5.08% |
| 2022 Q1 | 544.01 Million USD | -1.55% |
| 2022 Q3 | 487.67 Million USD | 3.68% |
| 2022 Q2 | 470.37 Million USD | -13.54% |
| 2022 FY | 450.22 Million USD | -18.53% |
| 2022 Q4 | 450.22 Million USD | -7.68% |
| 2021 FY | 552.6 Million USD | 135.32% |
| 2021 Q1 | 240.02 Million USD | 2.21% |
| 2021 Q2 | 520.96 Million USD | 117.05% |
| 2021 Q3 | 559.39 Million USD | 7.38% |
| 2021 Q4 | 552.6 Million USD | -1.21% |
| 2020 FY | 234.82 Million USD | 152.47% |
| 2020 Q3 | 195.88 Million USD | 71.88% |
| 2020 Q1 | 94.98 Million USD | 2.12% |
| 2020 Q2 | 113.97 Million USD | 19.98% |
| 2020 Q4 | 234.82 Million USD | 19.88% |
| 2019 FY | 93.01 Million USD | 104.57% |
| 2019 Q2 | 51.74 Million USD | 7.63% |
| 2019 Q4 | 93.01 Million USD | 10.43% |
| 2019 Q3 | 84.22 Million USD | 62.78% |
| 2019 Q1 | 48.07 Million USD | 5.73% |
| 2018 FY | 45.46 Million USD | 274.43% |
| 2018 Q4 | 45.46 Million USD | -2.11% |
| 2018 Q3 | 46.44 Million USD | 113.2% |
| 2018 Q2 | 21.78 Million USD | 77.23% |
| 2018 Q1 | 12.29 Million USD | 1.24% |
| 2017 Q3 | 8.88 Million USD | 4.71% |
| 2017 FY | 12.14 Million USD | 53.19% |
| 2017 Q4 | 12.14 Million USD | 36.72% |
| 2017 Q2 | 8.48 Million USD | -1.36% |
| 2017 Q1 | 8.59 Million USD | 8.47% |
| 2016 Q1 | 10.77 Million USD | -12.88% |
| 2016 FY | 7.92 Million USD | -35.92% |
| 2016 Q3 | 10.76 Million USD | 2.05% |
| 2016 Q4 | 7.92 Million USD | -26.37% |
| 2016 Q2 | 10.55 Million USD | -2.09% |
| 2015 Q4 | 12.36 Million USD | -6.47% |
| 2015 Q2 | 13.87 Million USD | -8.51% |
| 2015 Q1 | 15.16 Million USD | -5.68% |
| 2015 FY | 12.36 Million USD | -23.04% |
| 2015 Q3 | 13.22 Million USD | -4.65% |
| 2014 Q1 | 15.98 Million USD | 376.59% |
| 2014 Q3 | 14.25 Million USD | -3.73% |
| 2014 Q2 | 14.8 Million USD | -7.35% |
| 2014 FY | 16.07 Million USD | 379.31% |
| 2014 Q4 | 16.07 Million USD | 12.76% |
| 2013 Q3 | 3.2 Million USD | -6.69% |
| 2013 Q1 | 3.41 Million USD | 7.87% |
| 2013 FY | 3.35 Million USD | 5.79% |
| 2013 Q4 | 3.35 Million USD | 4.56% |
| 2013 Q2 | 3.43 Million USD | 0.52% |
| 2012 FY | 3.16 Million USD | 90.72% |
| 2012 Q4 | 3.16 Million USD | -7.26% |
| 2012 Q3 | 3.41 Million USD | 11.37% |
| 2012 Q2 | 3.06 Million USD | 64.19% |
| 2012 Q1 | 1.86 Million USD | 12.46% |
| 2011 FY | 1.66 Million USD | 26.96% |
| 2011 Q1 | 1.38 Million USD | 5.9% |
| 2011 Q2 | 1.47 Million USD | 6.18% |
| 2011 Q3 | 1.56 Million USD | 6.28% |
| 2011 Q4 | 1.66 Million USD | 6.24% |
| 2010 Q1 | 1.32 Million USD | -0.45% |
| 2010 FY | 1.3 Million USD | -1.87% |
| 2010 Q3 | 1.29 Million USD | -6.58% |
| 2010 Q4 | 1.3 Million USD | 1.19% |
| 2010 Q2 | 1.38 Million USD | 4.27% |
| 2009 FY | 1.33 Million USD | 13.95% |
| 2009 Q1 | 1.74 Million USD | 49.09% |
| 2009 Q4 | 1.33 Million USD | 1.83% |
| 2009 Q2 | 1.2 Million USD | -31.05% |
| 2009 Q3 | 1.31 Million USD | 8.85% |
| 2008 Q4 | 1.17 Million USD | -10.13% |
| 2008 FY | 1.17 Million USD | 61.24% |
| 2008 Q2 | 850.72 Thousand USD | -0.44% |
| 2008 Q3 | 1.3 Million USD | 53.12% |
| 2008 Q1 | 854.52 Thousand USD | 17.7% |
| 2007 Q4 | 726.01 Thousand USD | -51.01% |
| 2007 Q1 | 747.06 Thousand USD | 33.3% |
| 2007 Q2 | 1.17 Million USD | 57.32% |
| 2007 Q3 | 1.48 Million USD | 26.09% |
| 2007 FY | 726.01 Thousand USD | 29.55% |
| 2006 Q1 | 290.2 Thousand USD | -35.09% |
| 2006 Q4 | 560.43 Thousand USD | -22.71% |
| 2006 Q2 | 894.41 Thousand USD | 208.2% |
| 2006 FY | 560.43 Thousand USD | 25.35% |
| 2006 Q3 | 725.09 Thousand USD | -18.93% |
| 2005 FY | 447.1 Thousand USD | -46.34% |
| 2005 Q1 | 650.39 Thousand USD | -21.95% |
| 2005 Q2 | 462.13 Thousand USD | -28.95% |
| 2005 Q3 | 644.75 Thousand USD | 39.52% |
| 2005 Q4 | 447.1 Thousand USD | -30.65% |
| 2004 Q3 | 939.41 Thousand USD | -13.82% |
| 2004 FY | 833.26 Thousand USD | -71.89% |
| 2004 Q2 | 1.09 Million USD | -15.48% |
| 2004 Q4 | 833.26 Thousand USD | -11.3% |
| 2004 Q1 | 1.28 Million USD | -56.49% |
| 2003 Q3 | 340.02 Thousand USD | -20.59% |
| 2003 Q4 | 2.96 Million USD | 771.68% |
| 2003 Q2 | 428.19 Thousand USD | 15.3% |
| 2003 Q1 | 371.38 Thousand USD | 18.33% |
| 2003 FY | 2.96 Million USD | 844.38% |
| 2002 Q3 | 2.22 Million USD | -41.97% |
| 2002 Q4 | 313.84 Thousand USD | -85.9% |
| 2002 FY | 313.84 Thousand USD | -82.33% |
| 2002 Q1 | 1.61 Million USD | -9.35% |
| 2002 Q2 | 3.83 Million USD | 138.24% |
| 2001 Q4 | 1.77 Million USD | -19.22% |
| 2001 FY | 1.77 Million USD | -55.46% |
| 2001 Q3 | 2.19 Million USD | 10.34% |
| 2001 Q2 | 1.99 Million USD | -36.78% |
| 2001 Q1 | 3.15 Million USD | -20.96% |
| 2000 Q2 | 7.17 Million USD | 230.6% |
| 2000 Q4 | 3.98 Million USD | -20.19% |
| 2000 FY | 3.98 Million USD | 84.74% |
| 2000 Q3 | 4.99 Million USD | -30.35% |
| 2000 Q1 | 2.17 Million USD | 0.49% |
| 1999 Q3 | 2.68 Million USD | 6.77% |
| 1999 Q1 | 2.5 Million USD | -8.34% |
| 1999 Q4 | 2.16 Million USD | -19.4% |
| 1999 Q2 | 2.51 Million USD | 0.4% |
| 1999 FY | 2.15 Million USD | -20.84% |
| 1998 FY | 2.72 Million USD | -29.69% |
| 1998 Q1 | 3.1 Million USD | -20.08% |
| 1998 Q2 | 3 Million USD | -3.23% |
| 1998 Q3 | 3 Million USD | 0.0% |
| 1998 Q4 | 2.72 Million USD | -9.08% |
| 1997 Q4 | 3.87 Million USD | -9.79% |
| 1997 Q2 | 4.9 Million USD | -16.95% |
| 1997 Q1 | 5.9 Million USD | 0.0% |
| 1997 FY | 3.87 Million USD | -35.83% |
| 1997 Q3 | 4.3 Million USD | -12.24% |
| 1996 FY | 6.04 Million USD | -28.06% |
| 1996 Q1 | 7.1 Million USD | 16.39% |
| 1996 Q2 | 5.81 Million USD | -18.12% |
| 1996 Q3 | 6.8 Million USD | 16.97% |
| 1995 Q4 | 6.1 Million USD | -17.57% |
| 1995 Q1 | 9 Million USD | 0.0% |
| 1995 FY | 8.4 Million USD | -7.66% |
| 1995 Q2 | 8.4 Million USD | -6.63% |
| 1995 Q3 | 7.4 Million USD | -11.94% |
| 1994 Q2 | 9.1 Million USD | 22.97% |
| 1994 Q3 | 8.9 Million USD | -2.2% |
| 1994 Q1 | 7.4 Million USD | -10.84% |
| 1994 FY | 9.1 Million USD | 8.33% |
| 1993 Q4 | 8.3 Million USD | 2.47% |
| 1993 FY | 8.4 Million USD | -35.38% |
| 1993 Q3 | 8.1 Million USD | -3.57% |
| 1993 Q2 | 8.4 Million USD | -7.69% |
| 1993 Q1 | 9.1 Million USD | -8.08% |
| 1992 FY | 13 Million USD | 132.14% |
| 1992 Q3 | 11.8 Million USD | -9.23% |
| 1992 Q2 | 13 Million USD | 0.0% |
| 1992 Q4 | 9.9 Million USD | -16.1% |
| 1991 Q4 | 4.5 Million USD | 0.0% |
| 1991 FY | 5.6 Million USD | 60.0% |
| 1991 Q2 | 5.6 Million USD | 0.0% |
| 1990 Q3 | 3 Million USD | -14.29% |
| 1990 Q2 | 3.5 Million USD | 0.0% |
| 1990 FY | 3.5 Million USD | 600.0% |
| 1989 FY | 500 Thousand USD | 0.0% |
| 1989 Q2 | 500 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | -128.816% |
| AngioDynamics, Inc. | 317.67 Million USD | -29.919% |
| AtriCure, Inc. | 613.93 Million USD | 32.775% |
| Avinger, Inc. | 13.77 Million USD | -2897.197% |
| Azenta, Inc. | 2.88 Billion USD | 85.698% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 96.46% |
| Daxor Corporation | 34.86 Million USD | -1083.608% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | -1327.187% |
| Femasys Inc. | 27.75 Million USD | -1386.946% |
| GlucoTrack, Inc. | 4.9 Million USD | -8314.149% |
| Harvard Bioscience, Inc. | 137.36 Million USD | -200.448% |
| Hologic, Inc. | 9.15 Billion USD | 95.492% |
| ICU Medical, Inc. | 4.37 Billion USD | 90.574% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 97.327% |
| KORU Medical Systems, Inc. | 28.46 Million USD | -1350.105% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | -19.014% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -6536.594% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -6536.594% |
| Masimo Corporation | 3.04 Billion USD | 86.431% |
| Microbot Medical Inc. | 8.32 Million USD | -4856.335% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | -140.068% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | 82.251% |
| Nephros, Inc. | 11.86 Million USD | -3379.589% |
| NovoCure Limited | 1.14 Billion USD | 63.991% |
| NEXGEL, Inc. | 9.95 Million USD | -4045.796% |
| NEXGEL, Inc. | 9.95 Million USD | -4045.796% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | -55.467% |
| OraSure Technologies, Inc. | 482.84 Million USD | 14.525% |
| Pro-Dex, Inc. | 54.21 Million USD | -661.324% |
| Pulse Biosciences, Inc. | 60.8 Million USD | -578.761% |
| Predictive Oncology Inc. | 14.41 Million USD | -2762.64% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -2340.279% |
| QuidelOrtho Corporation | 8.56 Billion USD | 95.18% |
| Repligen Corporation | 2.82 Billion USD | 85.388% |
| Sanara MedTech Inc. | 73.87 Million USD | -458.694% |
| STAAR Surgical Company | 488.69 Million USD | 15.547% |
| Sharps Technology, Inc. | 11.78 Million USD | -3400.76% |
| Utah Medical Products, Inc. | 135.45 Million USD | -204.68% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 94.4% |
| Jin Medical International Ltd. | 32.9 Million USD | -1154.318% |